Added to YB: 2026-03-10
Pitch date: 2026-03-06
SNN [neutral]
Smith & Nephew plc
-2.55%
current return
Author Info
No bio for this author
Company Info
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Market Cap
GBP 14.6B
Pitch Price
GBP 12.73
Price Target
N/A
Dividend
2.27%
EV/EBITDA
11.75
P/E
24.02
EV/Sales
2.82
Sector
Health Care Equipment and Supplies
Category
growth
Theodosian Capital | Stocks Update 6/3/2026 - SN/ – FY results; Strong finish to 2025
SNN (update): FY25 rev $6.2B (+5.3% underlying), Q4 accelerated to +6.2% underlying. Op profit $794M (+21% YoY), margin expanded 160bps to 12.9%. OCF +24% to $1.5B. Net debt/EBITDA improved to 1.7x from 1.9x despite $500M buyback. 2026 guide: ~6% rev growth, ~8% trading profit growth to ~$1.3B, ~$800M FCF. Integrity acquisition dilutive in '26, neutral '27, accretive '28+. Trades 14.2x '27 EPS.
Read full article (1 min)